StockData
Stereotaxis, Inc. logo

Stereotaxis, Inc. (STXS) stock

STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.95+0.06 (+7.26%)

Close on Nov 18, 2026Market cap $94.80MP/E –Yield –

Stereotaxis operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Stereotaxis's operating cash flow for the twelve months ending Jun 30, 2026 was -$15.29M. For fiscal 2025 it was -$13.69M. The highest annual figure on record is -$2.53M in fiscal 2015.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$13.69M–
FY2024Dec 31, 2024-$8.50M–
FY2023Dec 31, 2023-$9.14M–
FY2022Dec 31, 2022-$8.42M–
FY2021Dec 31, 2021-$2.95M–
FY2020Dec 31, 2020-$3.51M–
FY2019Dec 31, 2019-$4.62M–
FY2018Dec 31, 2018-$2.55M–
FY2017Dec 31, 2017-$4.67M–
FY2016Dec 31, 2016-$6.56M–
FY2015Dec 31, 2015-$2.53M–
FY2014Dec 31, 2014-$9.09M–
FY2013Dec 31, 2013-$6.33M–
FY2012Dec 31, 2012-$12.12M–
FY2011Dec 31, 2011-$31.57M–
FY2010Dec 31, 2010-$18.91M–
FY2009Dec 31, 2009-$22.31M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.68M–
Q1 FY2026Mar 31, 2026-$3.44M–
Q4 FY2025Dec 31, 2025-$3.97M-413.5%
Q3 FY2025Sep 30, 2025-$4.20M–
Q2 FY2025Jun 30, 2025-$3.73M–
Q1 FY2025Mar 31, 2025-$1.78M–
Q4 FY2024Dec 31, 2024$1.27M–
Q3 FY2024Sep 30, 2024-$4.33M–
Q2 FY2024Jun 30, 2024-$3.09M–
Q1 FY2024Mar 31, 2024-$2.35M–
Q4 FY2023Dec 31, 2023-$2.44M–
Q3 FY2023Sep 30, 2023-$967.00K–
Q2 FY2023Jun 30, 2023-$2.93M–
Q1 FY2023Mar 31, 2023-$2.80M–
Q4 FY2022Dec 31, 2022-$2.55M–
Q3 FY2022Sep 30, 2022-$2.53M–
Q2 FY2022Jun 30, 2022-$1.14M-3444.1%
Q1 FY2022Mar 31, 2022-$2.19M–
Q4 FY2021Dec 31, 2021-$1.22M-495.8%
Q3 FY2021Sep 30, 2021-$1.46M–
Q2 FY2021Jun 30, 2021$34.00K–
Q1 FY2021Mar 31, 2021-$305.00K–
Q4 FY2020Dec 31, 2020$307.96K–
Q3 FY2020Sep 30, 2020-$482.98K–
Q2 FY2020Jun 30, 2020-$1.17M–
Q1 FY2020Mar 31, 2020-$2.17M–
Q4 FY2019Dec 31, 2019-$1.91M–
Q3 FY2019Sep 30, 2019-$405.85K–
Q2 FY2019Jun 30, 2019-$518.94K-205.9%
Q1 FY2019Mar 31, 2019-$1.78M–
Q4 FY2018Dec 31, 2018-$777.08K–
Q3 FY2018Sep 30, 2018-$238.35K–
Q2 FY2018Jun 30, 2018$490.23K–
Q1 FY2018Mar 31, 2018-$2.02M–
Q4 FY2017Dec 31, 2017-$802.75K–
Q3 FY2017Sep 30, 2017-$491.31K–
Q2 FY2017Jun 30, 2017-$713.20K–
Q1 FY2017Mar 31, 2017-$2.67M–
Q4 FY2016Dec 31, 2016-$131.68K–
Q3 FY2016Sep 30, 2016-$1.82M–

More Stereotaxis figures

See a number that looks wrong?